157 related articles for article (PubMed ID: 2166039)
1. Differences in targeting and secretion of cathepsins B and L by BALB/3T3 fibroblasts and Moloney murine sarcoma virus-transformed BALB/3T3 fibroblasts.
Achkar C; Gong QM; Frankfater A; Bajkowski AS
J Biol Chem; 1990 Aug; 265(23):13650-4. PubMed ID: 2166039
[TBL] [Abstract][Full Text] [Related]
2. The predominant secreted protein of transformed murine fibroblasts carries the lysosomal mannose 6-phosphate recognition marker.
Sahagian GG; Gottesman MM
J Biol Chem; 1982 Sep; 257(18):11145-50. PubMed ID: 6286683
[TBL] [Abstract][Full Text] [Related]
3. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
[TBL] [Abstract][Full Text] [Related]
4. Invasive properties of murine squamous carcinoma cells: secretion of matrix-degrading cathepsins is attributable to a deficiency in the mannose 6-phosphate/insulin-like growth factor II receptor.
Lorenzo K; Ton P; Clark JL; Coulibaly S; Mach L
Cancer Res; 2000 Aug; 60(15):4070-6. PubMed ID: 10945612
[TBL] [Abstract][Full Text] [Related]
5. Protein determinants impair recognition of procathepsin L phosphorylated oligosaccharides by the cation-independent mannose 6-phosphate receptor.
Lazzarino D; Gabel CA
J Biol Chem; 1990 Jul; 265(20):11864-71. PubMed ID: 2164020
[TBL] [Abstract][Full Text] [Related]
6. Mechanism for selective secretion of a lysosomal protease by transformed mouse fibroblasts.
Dong JM; Prence EM; Sahagian GG
J Biol Chem; 1989 May; 264(13):7377-83. PubMed ID: 2540189
[TBL] [Abstract][Full Text] [Related]
7. Autophagy, cathepsin L transport, and acidification in cultured rat fibroblasts.
Punnonen EL; Autio S; Marjomäki VS; Reunanen H
J Histochem Cytochem; 1992 Oct; 40(10):1579-87. PubMed ID: 1326577
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Colella R; Denhardt DT; Wilson SM
Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
[TBL] [Abstract][Full Text] [Related]
9. The identification of active forms of cysteine proteinases in Kirsten-virus-transformed mouse fibroblasts by use of a specific radiolabelled inhibitor.
Mason RW; Wilcox D; Wikstrom P; Shaw EN
Biochem J; 1989 Jan; 257(1):125-9. PubMed ID: 2537618
[TBL] [Abstract][Full Text] [Related]
10. The 46-kDa mannose 6-phosphate receptor does not depend on endosomal acidification for delivery of hydrolases to lysosomes.
Probst OC; Ton P; Svoboda B; Gannon A; Schuhmann W; Wieser J; Pohlmann R; Mach L
J Cell Sci; 2006 Dec; 119(Pt 23):4935-43. PubMed ID: 17105763
[TBL] [Abstract][Full Text] [Related]
11. Basis for low affinity binding of a lysosomal cysteine protease to the cation-independent mannose 6-phosphate receptor.
Dong JM; Sahagian GG
J Biol Chem; 1990 Mar; 265(8):4210-7. PubMed ID: 2155213
[TBL] [Abstract][Full Text] [Related]
12. Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.
Tournu C; Obled A; Roux MP; Ferrara M; Omura S; Béchet DM
Biochem J; 2001 Jul; 357(Pt 1):255-61. PubMed ID: 11415457
[TBL] [Abstract][Full Text] [Related]
13. Estrogen modulation of osteoclast lysosomal enzyme secretion.
Kremer M; Judd J; Rifkin B; Auszmann J; Oursler MJ
J Cell Biochem; 1995 Feb; 57(2):271-9. PubMed ID: 7759564
[TBL] [Abstract][Full Text] [Related]
14. [Cathepsins L and B and their endogenous inhibitors in embryonal fibroblasts transformed by different genes].
Dilakian EA; Vinokurova SV; Zhurbitskaia VA; Komissarova EV; Topol' LZ; Kiselev FL; Solov'eva NI
Vopr Med Khim; 1998; 44(1):35-42. PubMed ID: 9575611
[TBL] [Abstract][Full Text] [Related]
15. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.
Stearns NA; Dong JM; Pan JX; Brenner DA; Sahagian GG
Arch Biochem Biophys; 1990 Dec; 283(2):447-57. PubMed ID: 2275556
[TBL] [Abstract][Full Text] [Related]
16. The malignant phenotype and cysteine proteinases.
Sloane BF; Rozhin J; Krepela E; Ziegler G; Sameni M
Biomed Biochim Acta; 1991; 50(4-6):549-54. PubMed ID: 1801721
[TBL] [Abstract][Full Text] [Related]
17. Sensitization to the lysosomal cell death pathway upon immortalization and transformation.
Fehrenbacher N; Gyrd-Hansen M; Poulsen B; Felbor U; Kallunki T; Boes M; Weber E; Leist M; Jäättelä M
Cancer Res; 2004 Aug; 64(15):5301-10. PubMed ID: 15289336
[TBL] [Abstract][Full Text] [Related]
18. Cysteine endopeptidases and their inhibitors in malignant progression of rat embryo fibroblasts.
Sloane BF; Rozhin J; Moin K; Ziegler G; Fong D; Muschel RJ
Biol Chem Hoppe Seyler; 1992 Jul; 373(7):589-94. PubMed ID: 1515088
[TBL] [Abstract][Full Text] [Related]
19. Influence of 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) on the localization of cathepsin B and cathepsin L in human lung tumor cells.
Ulbricht B; Henny H; Horstmann H; Spring H; Faigle W; Spiess E
Eur J Cell Biol; 1997 Nov; 74(3):294-301. PubMed ID: 9402478
[TBL] [Abstract][Full Text] [Related]
20. Cysteine cathepsins are central contributors of invasion by cultured adenosylmethionine decarboxylase-transformed rodent fibroblasts.
Ravanko K; Järvinen K; Helin J; Kalkkinen N; Hölttä E
Cancer Res; 2004 Dec; 64(24):8831-8. PubMed ID: 15604241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]